相关实验视频

Updated: Mar 15, 2026

Flow Cytometry-based Drug Screening System for the Identification of Small Molecules That Promote Cellular Differentiation of Glioblastoma Stem Cells
10:28

Flow Cytometry-based Drug Screening System for the Identification of Small Molecules That Promote Cellular Differentiation of Glioblastoma Stem Cells

Published on: January 10, 2018

8.8K

将分子洞察力转化为有效的向质母细胞干细胞

Shilpi Singh1, Deepak Singh Kapkoti2,3, Gatikrushna Singh1

  • 1Department of Neurosurgery, University of Minnesota, Minneapolis, MN 55455, USA.

Cancers
|March 14, 2026
PubMed
概括

质母细胞 (GSCs) 具有适应性,通过激活弹性途径来驱动瘤复发. 新的疗法必须同时针对多个GSC电路,以持续控制质母细胞瘤.

关键词:
质母细胞的干细胞没有编码的RNA.治疗性抗药性是一种治疗性抗药性.瘤微环境是一个微环境.

更多相关视频

Image-Guided Resection of Glioblastoma and Intracranial Implantation of Therapeutic Stem Cell-seeded Scaffolds09:18

Image-Guided Resection of Glioblastoma and Intracranial Implantation of Therapeutic Stem Cell-seeded Scaffolds

Published on: July 16, 2018

8.8K
Processing of Primary Brain Tumor Tissue for Stem Cell Assays and Flow Sorting08:14

Processing of Primary Brain Tumor Tissue for Stem Cell Assays and Flow Sorting

Published on: September 25, 2012

18.7K

相关概念视频

Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
6.3K